Pharma news
Pharma
Alexion Pharmaceuticals is to acquire immune-system specialist Achillion for almost $1 billion dollars. 17 October 2019
Pharma
Brexit uncertainty is already having a negative impact on UK science, according to The Royal Society, the UK’s national academy of sciences. 17 October 2019
Pharma
Uncertainty surrounding the patentability of artificial intelligence (AI) and changes to patented medicine pricing in Canada were two topics discussed yesterday, October 15 at Life Sciences Patent Network Fall in San Francisco. 17 October 2019
Asia
The Philippines’ deputy IP chief has warned e-commerce platforms that they could be made liable for the sale of counterfeit goods on their sites under new legislation, amid fears over the spread of counterfeit pharmaceuticals. 15 October 2019
Pharma
Belgium head-quartered pharmaceutical company UCB is to acquire Ra Pharmaceuticals for approximately $2.1 billion. 14 October 2019
Pharma
Actavis Laboratories cannot market a generic version of Horizon Pharma’s knee pain treatment, an appeals court has ruled. 11 October 2019
Pharma
Johnson & Johnson has committed $500 million to research and development programmes over the next four years in a bid to eliminate HIV and tuberculosis across the world by 2030. 10 October 2019
Pharma
African drugmaker Aspen was able to increase its prices for fludrocortisone acetate tablets by 1,800% in the UK, as a result of collusion with two other firms, according to the UK’s Competition and Markets Authority. 9 October 2019
Americas
California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry. 9 October 2019
Pharma
The English High Court has sided with pharmaceutical company Vectura and Novartis-owned Sandoz in a passing off lawsuit brought by rival GSK. 8 October 2019